In experimental autoimmune encephalomyelitis, activin-A suppressed the pathogenic signature and the encephalitogenic functions of Th17 cells, at least partly through the enhanced expression of the anti-inflammatory ectonucleotidases CD73 and CD39 [50]. Here, ENTPD1 is linked to experimental autoimmune encephalomyelitis.